Evidence map›Paper›PMID 36339566›Full record

ReviewFrontiers in pharmacology2022

Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy.

Yuting Cui, Chuang Li, Feng Sang, Weiling Cao, Zhuo Qin, Peng Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer.International journal of biological sciences · 2024
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuting CuiSchool of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, China.
Chuang LiSchool of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, China.
Feng SangSchool of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, China.
Weiling CaoDepartment of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, China.
Zhuo QinDepartment of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, China.
Peng ZhangDepartment of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, China.
Shandong University of Technology · CNShenzhen Luohu People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycolysis is a complex metabolic process that occurs to convert glucose into pyruvate to produce energy for living cells. Normal cells oxidized pyruvate into adenosine triphosphate and carbon dioxide in the presence of oxygen in mitochondria while cancer cells preferentially metabolize pyruvate to lactate even in the presence of oxygen in order to maintain a slightly acidic micro-environment of PH 6.5 and 6.9, which is beneficial for cancer cell growth and metastasis. Therefore targeting glycolytic signaling pathways provided new strategy for anti-cancer therapy. Natural products are important sources for the treatment of diseases with a variety of pharmacologic activities. Accumulated studies suggested that natural products exhibited remarkable anti-cancer properties both

Indexed as

anti-cancerglycolysishexokinase (HK)natural compoundsphosphofructokinase-1 (PFK-1)pyruvate kinase (PK)

Identifiers

PMID36339566
PMCPMC9631946
OpenAlexW4306871003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.